发明名称 |
Safe vectors for gene therapy |
摘要 |
The present invention provides retroviral vectors comprising direct repeats flanking a sequence that is desired to be deleted upon reverse transcription in a host cell. In a preferred embodiment the sequence that is desired to be deleted is the retroviral cis-acting encapsidation sequence (E) essential for virus production in helper cells. In gene therapy embodiments, the E sequence is deleted upon reverse transcription in target cells, thus preventing spread of retroviral vectors to non-target cells in the event of infection with replication competent viruses. The retroviral vectors of the present invention thus provide safe vectors for gene therapy.
|
申请公布号 |
US5714353(A) |
申请公布日期 |
1998.02.03 |
申请号 |
US19940248132 |
申请日期 |
1994.05.24 |
申请人 |
RESEARCH CORPORATION TECHNOLOGIES, INC. |
发明人 |
PATHAK, VINAY K.;HU, WEI-SHAU |
分类号 |
C12N15/09;A61K31/70;A61K35/76;A61K38/00;A61K38/22;A61K38/43;A61K48/00;A61P7/06;A61P9/10;A61P31/12;A61P43/00;C07H21/04;C12N5/00;C12N5/10;C12N7/00;C12N15/867;C12R1/91;C12R1/92;(IPC1-7):C12N15/64;C12N15/79;C12N1/20 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|